Gregory Renza
Stock Analyst at Truist Financial
(4.87)
# 344
Out of 4,966 analysts
844
Total ratings
56.8%
Success rate
19.5%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Reiterated: Buy | n/a | $73.16 | - | 23 | Sep 10, 2026 | |
| MNKD MannKind | Reiterated: Buy | n/a | $3.75 | - | 39 | Sep 10, 2026 | |
| AMGN Amgen | Reiterated: Hold | n/a | $377.35 | - | 41 | Sep 8, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | n/a | $203.77 | - | 9 | Sep 3, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | n/a | $37.59 | - | 34 | Sep 1, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | n/a | $245.80 | - | 44 | Sep 1, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | n/a | $21.24 | - | 37 | Sep 1, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | n/a | $143.72 | - | 17 | Aug 28, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | n/a | $16.10 | - | 5 | Aug 21, 2026 | |
| FULC Fulcrum Therapeutics | Reiterated: Hold | n/a | $3.80 | - | 18 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.47 | - | 6 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.60 | - | 45 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.81 | +291.46% | 19 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $26.24 | +21.95% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.07 | +114.17% | 28 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $52 | $56.12 | -7.34% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $416 → $418 | $346.51 | +20.63% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.41 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.86 | +81.35% | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $769 → $772 | $781.49 | -1.21% | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 | $31.98 | +159.54% | 2 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $25.61 | +32.79% | 27 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $155 | $118.64 | +30.65% | 12 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $27.83 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.05 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.25 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $4.91 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.32 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $46 | $0.6603 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $25.22 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $0.4298 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $7.83 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 | $53.70 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $16.12 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20.41 | $2.30 | n/a | 23 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $80 | $0.77395 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $15 | $0.000001 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $217.15 | n/a | 1 | Sep 8, 2015 |
CG Oncology
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $73.16
Upside: -
MannKind
Sep 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.75
Upside: -
Amgen
Sep 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $377.35
Upside: -
Revolution Medicines
Sep 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $203.77
Upside: -
IDEAYA Biosciences
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.59
Upside: -
Jazz Pharmaceuticals
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $245.80
Upside: -
Viridian Therapeutics
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $21.24
Upside: -
Gilead Sciences
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $143.72
Upside: -
Ascentage Pharma Group International
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.10
Upside: -
Fulcrum Therapeutics
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.80
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.47
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $33.60
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
Aug 11, 2026
Reiterated: Buy
Price Target: $32
Current: $26.24
Upside: +21.95%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $6.07
Upside: +114.17%
Aug 6, 2026
Reiterated: Hold
Price Target: $52
Current: $56.12
Upside: -7.34%
Aug 6, 2026
Reiterated: Buy
Price Target: $416 → $418
Current: $346.51
Upside: +20.63%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.41
Upside: -
Jul 31, 2026
Reiterated: Hold
Price Target: $7
Current: $3.86
Upside: +81.35%
Jul 31, 2026
Reiterated: Buy
Price Target: $769 → $772
Current: $781.49
Upside: -1.21%
Jul 30, 2026
Reiterated: Buy
Price Target: $83
Current: $31.98
Upside: +159.54%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $25.61
Upside: +32.79%
Jul 2, 2026
Reiterated: Buy
Price Target: $135 → $155
Current: $118.64
Upside: +30.65%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $27.83
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $8
Current: $1.05
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $5
Current: $1.25
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $20
Current: $4.91
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $7.32
Upside: n/a
May 12, 2025
Reiterated: Buy
Price Target: $48 → $46
Current: $0.6603
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $26
Current: $25.22
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $16
Current: $0.4298
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $12 → $13
Current: $7.83
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $38
Current: $53.70
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $16.12
Upside: n/a
May 15, 2023
Reiterated: Hold
Price Target: $20.41
Current: $2.30
Upside: n/a
Mar 16, 2022
Reiterated: Hold
Price Target: $5 → $80
Current: $0.77395
Upside: n/a
Nov 12, 2021
Reiterated: Hold
Price Target: $1 → $15
Current: $0.000001
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $217.15
Upside: n/a